Replies to post #174741 on Biotech Values

[DewDiligence]

IMUC +66% PM on reaching an SPA for glioblastoma trial:

http://finance.yahoo.com/news/immunocellular-therapeutics-reaches-agreement-fda-100000647.html

Nutty behavior in biotech microcaps continues.